Continuity instead of shareholder value
SCHWIND eye-tech-solutions is the only family business in the market segment run by the owner and this sets the company apart from all the competitors listed on the stock exchange. This company background has its origins in a promise passed on from founder Herbert Schwind to today’s CEO Rolf Schwind: a commitment to continuity instead of shareholder value. Accordingly, customer relationships are also long-term and closely applied. The customers practically form part of the SCHWIND family.
High-Tech demands High-Touch: SCHWIND also gives at most importance to individually-optimized consultation and customer care. In this way, the refractive surgeon is comprehensively supported from the beginning by one source. This includes continuous and professional far-reaching applicative clinical support through the Customer Support department, as well as through the services of the Technical Service department.
Closely geared
A fundamental factor for the high quality of SCHWIND technologies is the practical development: The R & D department co-operates closely with the customer support and service departments. Thus, experience from clinics and practices is integrated into product developments and provides incentives for innovations. The company is in constant dialog with its customers. Renowned refractive surgeons throughout the world evaluate the developments and give their critical and constructive feedback. This results in products which support doctors in providing optimized treatments for their patients, furnishing them with highly predictable results. In connection to this is a longer service life and therefore increased security of investment.
Current Issue :
"No-Touch“ Surface Treatment with SCHWIND AMARIS: TransPRK allows highly precise and easy removal of the epithelium and refractive laser treatment in one step
[more]Innovation:
With the unique Intelligent Thermal Effect Control (ITEC) of the SCHWIND AMARIS, the patient’s cornea is warmed less than four degrees during the laser treatment.
[more]